Top Markets
Coin of the day
AegirBio AB (publ) AegirBio AB (publ)

AegirBio AB (publ)

AEGIR
Rank in Stocks #38668
AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden.... AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden. The company specializes in developing and commercializing tests primarily aimed at monitoring the dosage of biological drugs. Their efforts are concentrated on therapeutic drug monitoring for biologic therapies across various conditions, including multiple sclerosis, different types of cancer, and autoimmune diseases. Among their offerings are moNATor, a pioneering laboratory test designed for dose monitoring in multiple sclerosis for both medical professionals and patients, and Viraspec, a saliva-based test kit for COVID-19 detection.
Share Price
$0.04057595
Last synced: 2024-08-05
Market Cap
$863.62K
Change (1 day)
0.31%
Change (1 year)
0.00%
Country
SE
Trade AegirBio AB (publ) (AEGIR)

Category

Number of shares outstanding for AegirBio AB (publ) (AEGIR)
Number of shares outstanding as of September 2024: 35.39M
According to AegirBio AB (publ) latest financial reports and stock price the company's current number of shares outstanding is 35.39M. At the end of December 2022 the company had 19.20M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for AegirBio AB (publ) (AEGIR) from 2019 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 35.39M 41.25%
2023 25.05M 30.48%
2022 19.20M 17.22%
2021 16.38M 40.13%
2020 11.69M 60.07%
2019 7.30M 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
354.50M 901.72%
US
461.20M 1,203.23%
FR
- -
JP
274.79M 676.48%
US
- -
CH